Article

Oncologists Raise a Voice Against Cancer Drug Costs

Hagop Kantarjian, MD, from MD Anderson is at it again. A special publication online, written in collaboration with S. Vincent Kumar, MD, from the Mayo Clinic, highlights the dismal state of the economics behind high oncology drug costs and recommends solutions.

Increasingly high prices for cancer drugs are affecting patient care in the United States. and the American healthcare system overall, say the authors of a special article published online in the journal Mayo Clinic Proceedings.

“Americans with cancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries,” says S

, of Mayo Clinic Cancer Center

,

who is one of the authors. “As oncologists we have a moral obligation to advocate for affordable cancer drugs for our patients.”

. Vincent Raj Kumar

Link to the news release by the Mayo Clinic: http://mayocl.in/1Gd7cMB

Related Videos
Emma Achola-Kothari, PhD
Dr Emma Achola-Kothani
Nini Wu, MD, Navista
Dr Emma Achola-Kothari
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Lalan Wilfong, MD
Katherine Baker, MD, MMHC
Nini Wu, MD, MBA
Casey Koch, PharmD, sitting for a video interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo